439
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid

, &
Pages 78-85 | Received 09 Jan 2015, Accepted 18 Jun 2015, Published online: 08 Jul 2015

References

  • Wójcicka J, Sieńko J, Smolarczyk R, Romejko E, Grymowicz M, Czajkowski K. Alpha-hydroxybutyrate dehydrogenase activity in intrahepatic cholestasis of pregnency. Int J Gynecol Obstet 2005;89:247–50.
  • Reid R, Ivey K, Rencoret R, Storey B. Fetal complications of obstetric cholestasis. BMJ 1976;1:870–2.
  • Rioseco AJ, Ivancovic MB, Manzur A, Hamed F, Kato SR, Parer JT, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994;170:890–5.
  • Gaudet R, Merviel P, Berkane N, Schouppe S, Cocheton JJ, Uzan S. Fetal impact of cholestasis of pregnancy: experience at Tenon Hospital and literature review. Fetal Diagn Ther 2000;15:191–7.
  • Roncaglia N, Arreghini A, Locatelli A, Bellini P, Andreotti C, Ghidini A. Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol 2002;100:167–70.
  • Glantz A, Marschall HU, Mattson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004;40:467–74.
  • Zapata R, Sandoval L, Palma J, Hernández I, Ribalta J, Reyes H, et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int 2005;25:548–54.
  • Geenes V, Williamson C. Intrahepatic cholestasis of pregnency. World J Gastroenterol 2009;15:2049–66.
  • Germain AM, Kato S, Carvajal JA, Valenzuela GJ, Valdes GL, Glasinovic JC. Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol 2003;189:577–82.
  • Israel EJ, Guzman ML, Campos GA. Maximal response to oxytocin of the isolated myometrium from pregnant patients with intrahepatic cholestasis. Acta Obstet Gynecol Scand 1986;65:581–2.
  • Zecca E, Costa S, Lauriola V, Vento G, Papacci P, Romagnoli C. Bile acid pneumonia: a “new” form of neonatal respiratory distress syndrome? Pediatrics 2004;114:269–72.
  • Gorelik J, Harding SE, Shechuk A, Koralage D, Lab M, de Swiet M, et al. Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci 2002;103:191–200.
  • Sepulveda W. Vasoconcrtrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol 1991;42:211–13.
  • Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez MC, Hernandez I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992;15:1043–7.
  • Meng LJ, Reyes H, Palma J, Hernandez I, Ribalta J, Sjövall J. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J Hepatol 1997;27:1029–40.
  • Zusman I, Zimber A. Effects of secondary bile acids on the in vitro development of early somite embryos. Acta Anat 1990;138:144–9.
  • Zimber A, Zusman I. Effects of secondary bile acids on the intrauterine development in rats. Teratology 1990;42:215–24.
  • Hempfling W, Dilger K, Beuers U. Systematic review: ursodeoxycholic acid – adverse effects and drug interactions. Aliment Pharmacol Ther 2003;18:963–72.
  • Brites D. Intrahepatic cholestasis of pregnancy: changes in materanal-fetal bile acid balance and improvement by ursodeoxycholic acid. Ann Hepatol 2002;1:20–8.
  • Berkane N, Cocheton JJ, Brehier D, Merviel P, Wolf C, Lefèvre G, et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scan 2000;79:941–6.
  • Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, et al. Ursodeoxycholic acid administration in patients with cholstasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001;33:504–8.
  • Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JC. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Maternal Fetal Med 2001;10:131–5.
  • Milkiewicz P, Gallagher R, Chambers J, Eggington E, Weaver J, Elias E. Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment. J Gastroenterol Hepatol 2003;18:1283–6.
  • Azzaroli F, Mennone A, Feletti V, Simoni P, Baglivo E, Montagnani M, et al. Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. Aliment Phatmacol Ther 2007;26:1139–46.
  • Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR. The importance of serum blie level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestsis of pregnancy: a case series from central Europe. Arch Dermatol 2007;143:757–62.
  • Baliutaviciene D, Zubruviene N, Zalinkevicius R. Pregnancy outcome in cases of intrahepatic cholestasis of pregnancy. Int J Gynecol Obstet 2011;112:250–1.
  • Isla CR, Cappelletti CA, Tielli G. Value of ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. Gastroenterology 1996;110:1219.
  • Palma J, Reyes H, Ribalta J, Hernández I, Sandoval L, Almuna R, et al. Ursodeoxyxholic acid in the treatment of cholstasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997;27:1022–8.
  • Diaferia A, Nicastri PL, Tartagni M, Loizzi P, Iacovizzi C, Di Leo A. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynecol Obstet 1996;52:133–40.
  • Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, et al. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic therapy. Hepatology 1997;26:1573–9.
  • Nicastri PL, Diaferia A, Tartagni M, Loizzi P, Fanelli M. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intraheaptic cholestasis of pregnancy. Brit J Obstet Gynaecol 1998;105:1205–7.
  • Floreani A, Pternoster D, Melis A, Grella PV. S-adenosylmethionine versus ursodoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Europ J Obstet Gynecol 1996;67:109–13.
  • Binder T, Salaj P, Zima T, Vítek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006;34:383–91.
  • Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005;42:1399–405.
  • Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU. Intrahepatic choelstasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 2008;47:544–51.
  • Kondrackiene J, Beuers U, Kupcinskas L. Efficiacy and safety of ursodeoxycholic acid versus cholestyramine in intraheparic cholestasis of pregnancy. Gastroenterology 2005;29:894–901.
  • Bacq Y, Sentilhes Z, Reveste B, Glantz A, Kondrackiene J, Binder T, et al. Efficiacy of ursodeoxycholic acid in treating intrachepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 2012;143:1492–501.
  • Sentilhes L, Verspyck E, Pia P, Marpeau L. Fetal death in a patient with intrahepatic cholestasis of pregnancy. Obstet Gynecol 2006;107:458–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.